Peiwu Geng

1.5k total citations · 1 hit paper
84 papers, 1.0k citations indexed

About

Peiwu Geng is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Peiwu Geng has authored 84 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 33 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in Peiwu Geng's work include Pharmacogenetics and Drug Metabolism (23 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Pharmacological Effects of Natural Compounds (8 papers). Peiwu Geng is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Pharmacological Effects of Natural Compounds (8 papers). Peiwu Geng collaborates with scholars based in China, Bangladesh and Pakistan. Peiwu Geng's co-authors include Shuanghu Wang, Yunfang Zhou, Da‐Peng Dai, Guoxin Hu, Jian Xiao, Abdullah Al Mamun, Xianqin Wang, Jian‐Ping Cai, Congcong Wen and Jianshe Ma and has published in prestigious journals such as Frontiers in Immunology, BioMed Research International and Pharmacological Research.

In The Last Decade

Peiwu Geng

83 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent advances in molecular mechanisms of skin wound healing and its treatments

2024 89 citations Abdullah Al Mamun, Peiwu Geng et al. profile →

Peers

Peiwu Geng

PHARM

ONCOL

Sally A. El Awdan Egypt

Chunyong Wu China

Manju Vaiyapuri India

Ying Peng China

Meijuan Xu China

Gurdarshan Singh India

Amira M. Abo‐Youssef Egypt

Xia Wu China

Fardous F. El‐Senduny Egypt

Qi Dong China

Sally A. El Awdan Egypt

Peiwu Geng

220 ×0.5

PHARM

365 ×1.2

150 ×0.8

PHARM

99 ×0.6

ONCOL

142 ×1.3

Citations per year, relative to Peiwu Geng Peiwu Geng (= 1×) peers Sally A. El Awdan

Countries citing papers authored by Peiwu Geng

Since Specialization

Citations

This map shows the geographic impact of Peiwu Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwu Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwu Geng more than expected).

Fields of papers citing papers by Peiwu Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiwu Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwu Geng. The network helps show where Peiwu Geng may publish in the future.

Co-authorship network of co-authors of Peiwu Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Peiwu Geng. A scholar is included among the top collaborators of Peiwu Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiwu Geng. Peiwu Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Younas, Ayesha, Shuanghu Wang, Muhammad Asad, et al.. (2025). Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology. Materials Today Bio. 36. 102660–102660.

Molla, Abul Hossain, M. Nazmul Hoque, Fahmida Tasnim Richi, et al.. (2025). Biosynthesis and Characterization of ZnO Nanoparticles Using Citrus reticulata Peel Followed by Photocatalytic, Antibacterial, and Antioxidative Nanotherapeutic Attributes Assessment Supported by Computer Simulation. International Journal of Nanomedicine. Volume 20. 4803–4829. 6 indexed citations

Mamun, Abdullah Al, et al.. (2024). Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?. International Journal of Biological Sciences. 20(4). 1332–1355. 48 indexed citations

Mamun, Abdullah Al, et al.. (2024). Targeting Remyelination in Spinal Cord Injury: Insights and Emerging Therapeutic Strategies. CNS Neuroscience & Therapeutics. 30(12). 1–15. 4 indexed citations

Shao, Chuxiao, et al.. (2024). Recent advances in the role of neuroregulation in skin wound healing. Burns & Trauma. 13. tkae072–tkae072. 1 indexed citations

Mamun, Abdullah Al, Peiwu Geng, Shuanghu Wang, & Chuxiao Shao. (2024). Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation. Journal of Inflammation Research. Volume 17. 7037–7056. 3 indexed citations

Song, Wei, et al.. (2024). The Impact of Baohuoside I on the Metabolism of Tofacitinib in Rats. Drug Design Development and Therapy. Volume 18. 931–939. 2 indexed citations

Mamun, Abdullah Al, Chuxiao Shao, Peiwu Geng, Shuanghu Wang, & Jian Xiao. (2024). Pyroptosis in Diabetic Peripheral Neuropathy and its Therapeutic Regulation. Journal of Inflammation Research. Volume 17. 3839–3864. 6 indexed citations

Mamun, Abdullah Al, Chuxiao Shao, Peiwu Geng, Shuanghu Wang, & Jian Xiao. (2024). The Mechanism of Pyroptosis and Its Application Prospect in Diabetic Wound Healing. Journal of Inflammation Research. Volume 17. 1481–1501. 10 indexed citations

10.

Zhang, Qing, Shuanghu Wang, Lili Zou, et al.. (2023). Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects. Frontiers in Endocrinology. 14. 6 indexed citations

11.

Xia, Mengming, Yu Wang, Peiwu Geng, et al.. (2023). Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS. Thoracic Cancer. 14(33). 3331–3341. 3 indexed citations

12.

Wang, Shuanghu, Mengming Xia, Yu Wang, et al.. (2023). Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS. Thoracic Cancer. 14(14). 1276–1285. 1 indexed citations

13.

Wu, Qingjun, Shuanghu Wang, Jian Liu, et al.. (2022). Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity. Thoracic Cancer. 13(6). 853–857. 2 indexed citations

14.

Wang, Shuanghu, Quan Zhou, Peiwu Geng, et al.. (2021). Biodegradability of Micro/Nanomotors: Challenges and Opportunities. Advanced Healthcare Materials. 10(13). e2100335–e2100335. 29 indexed citations

15.

Wang, Bo, Feifei Chen, Yunfang Zhou, et al.. (2020). Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS. International Journal of Analytical Chemistry. 2020. 1–6. 1 indexed citations

16.

Zhou, Yunfang, et al.. (2020). Inhibitory Effect of Lygodium Root on the Cytochrome P450 3A Enzyme in vitro and in vivo. Drug Design Development and Therapy. Volume 14. 1909–1919. 9 indexed citations

17.

Chen, Feifei, Hui Jiang, Shuanghu Wang, et al.. (2020). In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine. Drug Design Development and Therapy. Volume 14. 4815–4824. 10 indexed citations

18.

Wu, Qingjun, Hui Jiang, Shuanghu Wang, et al.. (2020). Effects of avitinib on the pharmacokinetics of osimertinib in vitro and in vivo in rats. Thoracic Cancer. 11(10). 2775–2781. 13 indexed citations

19.

Wang, Bo, Shuanghu Wang, Feifei Chen, et al.. (2020). Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats. Drug Design Development and Therapy. Volume 14. 2199–2206. 15 indexed citations

20.

Dai, Da‐Peng, et al.. (2015). In vitrofunctional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population. Xenobiotica. 45(11). 1030–1035. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact